Ketchum to promote women's drug portfolio

Drugs firm Bayer Schering has taken on its first PR support for its women's healthcare portfolio.

Ketchum will handle global PR activity for the pharma firm's women's healthcare products. The portfolio includes products for female contraception, menopause management and gynaecological therapies.

Ketchum was appointed to the account following a competitive pitch against four undisclosed agencies at Bayer Schering's Berlin headquarters.

The agency is charged with targeting women and their partners who are 'of a reproductive age' as part of the brief.

Ketchum will also seek to overcome challenges surrounding cultural and religious sensitivities to contraception, and the misconceptions about the role of hormones as part of the PR activity.

The account will be overseen by Ketchum associate director Cat Barnett with support from a team of five.

The Ketchum team will report into Bayer Schering head of brand comms and services Ludwig Hahn.

Ketchum announced last month that it would place greater emphasis on clinical trial recruitment services after merging with US-based healthcare comms agency MMG (PRWeek, 22 February).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in